Abemaciclib, an inhibitor of CDK4 and CDK6, combined with endocrine and HER2-targeted therapies for women with metastatic breast cancer Meeting Abstract
| Authors: | Goetz, M. P.; Beeram, M.; Beck, T.; Conlin, A. K.; Dees, E. C.; Dickler, M. N.; Helsten, T. L.; Conkling, P. R.; Edenfield, W. J.; Richards, D. A.; Turner, P. K.; Cai, N.; Chan, E. M.; Pant, S.; Becerra, C. H.; Kalinsky, K.; Puhalla, S. L.; Rexer, B. N.; Burris, H. A.; Tolaney, S. M. |
| Abstract Title: | Abemaciclib, an inhibitor of CDK4 and CDK6, combined with endocrine and HER2-targeted therapies for women with metastatic breast cancer |
| Meeting Title: | 38th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) |
| Journal Title: | Cancer Research |
| Volume: | 76 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2015 Dec 8-12 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2016-02-15 |
| Language: | English |
| ACCESSION: | WOS:000375622403236 |
| PROVIDER: | wos |
| DOI: | 10.1158/1538-7445.SABCS15-P4-13-25 |
| Notes: | Meeting Abstract: P4-13-25 -- Source: Wos |
